Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia.
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):983-9. doi: 10.1007/s00259-012-2088-x. Epub 2012 Mar 8.
Amyloid imaging with (18)F-labelled radiotracers will allow widespread use of this technique, facilitating research, diagnosis and therapeutic development for Alzheimer's disease (AD). The purpose of this analysis was to compare data on cortical Aβ deposition in subjects who had undergone both (11)C-PiB (PiB) and (18)F-florbetaben (FBB) PET imaging.
We identified ten healthy elderly controls (HC) and ten patients with AD who had undergone PET imaging after intravenous injection of 370 MBq of PiB and 300 MBq of FBB under separate research protocols. PiB and FBB images were coregistered so that placement of regions of interest was identical on both scans and standard uptake value ratios (SUVR) using the cerebellar cortex as reference region were calculated between 40 and 70 min and between 90 and 110 min after injection for PiB and FBB, respectively.
Significantly higher SUVR values (p < 0.0001) in most cortical areas were observed in AD patients when compared with HC with both radiotracers. Global SUVR values in AD patients were on average 75% higher than in HC with PiB and 56% higher with FBB. There was an excellent linear correlation between PiB and FBB global SUVR values (r = 0.97, p < 0.0001) with similar effect sizes for distinguishing AD from HC subjects for both radiotracers (Cohen's d 3.3 for PiB and 3.0 for FBB).
FBB, while having a narrower dynamic range than PiB, clearly distinguished HC from AD patients, with a comparable effect size. FBB seems a suitable (18)F radiotracer for imaging AD pathology in vivo.
使用(18)F 标记的放射性示踪剂进行淀粉样蛋白成像将允许广泛使用该技术,从而促进阿尔茨海默病(AD)的研究、诊断和治疗开发。本分析的目的是比较接受过(11)C-PiB(PiB)和(18)F-氟比他滨(FBB)正电子发射断层扫描(PET)成像的受试者皮质 Aβ 沉积数据。
我们确定了十位接受过静脉注射 370MBq PiB 和 300MBq FBB 的健康老年对照(HC)和十位 AD 患者。PiB 和 FBB 图像进行了配准,使得在这两种扫描中放置感兴趣区域的位置相同,并计算了注射后 40-70 分钟和 90-110 分钟时使用小脑皮质作为参考区域的 PiB 和 FBB 的标准摄取值比(SUVR)。
与 HC 相比,AD 患者的大多数皮质区域的 SUVR 值(p < 0.0001)明显更高,用两种示踪剂均如此。AD 患者的全局 SUVR 值平均比 HC 用 PiB 高 75%,用 FBB 高 56%。PiB 和 FBB 的全局 SUVR 值之间存在极好的线性相关性(r = 0.97,p < 0.0001),两种示踪剂在区分 AD 与 HC 受试者方面的效果大小相似(PiB 的 Cohen's d 为 3.3,FBB 为 3.0)。
FBB 虽然比 PiB 的动态范围窄,但能明确区分 HC 与 AD 患者,效果大小相当。FBB 似乎是一种适合用于体内成像 AD 病理的(18)F 放射性示踪剂。